[go: up one dir, main page]

GB0605781D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB0605781D0
GB0605781D0 GB0605781A GB0605781A GB0605781D0 GB 0605781 D0 GB0605781 D0 GB 0605781D0 GB 0605781 A GB0605781 A GB 0605781A GB 0605781 A GB0605781 A GB 0605781A GB 0605781 D0 GB0605781 D0 GB 0605781D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0605781A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hansa Biopharma AB
Original Assignee
Hansa Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansa Medical AB filed Critical Hansa Medical AB
Priority to GB0605781A priority Critical patent/GB0605781D0/en
Publication of GB0605781D0 publication Critical patent/GB0605781D0/en
Priority to CN200680028126.3A priority patent/CN101232900B/en
Priority to EP06754207A priority patent/EP1901773B1/en
Priority to ES06754207T priority patent/ES2380950T3/en
Priority to PL06754207T priority patent/PL1901773T3/en
Priority to AU2006256891A priority patent/AU2006256891B2/en
Priority to CA2611646A priority patent/CA2611646C/en
Priority to CN201610049256.0A priority patent/CN105770871A/en
Priority to PCT/EP2006/005454 priority patent/WO2006131347A2/en
Priority to AT06754207T priority patent/ATE548049T1/en
Priority to JP2008515137A priority patent/JP5427409B2/en
Priority to US11/921,770 priority patent/US8133483B2/en
Priority to PT06754207T priority patent/PT1901773E/en
Priority to NL301089C priority patent/NL301089I2/en
Priority to FR21C1004C priority patent/FR21C1004I2/en
Priority to BE2021C505C priority patent/BE2021C505I2/fr
Ceased legal-status Critical Current

Links

GB0605781A 2005-06-09 2006-03-22 Treatment Ceased GB0605781D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0605781A GB0605781D0 (en) 2006-03-22 2006-03-22 Treatment
PT06754207T PT1901773E (en) 2005-06-09 2006-06-08 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
CA2611646A CA2611646C (en) 2005-06-09 2006-06-08 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
PCT/EP2006/005454 WO2006131347A2 (en) 2005-06-09 2006-06-08 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
ES06754207T ES2380950T3 (en) 2005-06-09 2006-06-08 Use of the IdeS proteinase (from S, pyogenes) to treat autoimmune diseases and graft rejection
PL06754207T PL1901773T3 (en) 2005-06-09 2006-06-08 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
AU2006256891A AU2006256891B2 (en) 2005-06-09 2006-06-08 Use of the ideS proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
CN200680028126.3A CN101232900B (en) 2005-06-09 2006-06-08 Use of IdeS protease (from Streptococcus pyogenes) in the treatment of autoimmune diseases and transplant rejection
CN201610049256.0A CN105770871A (en) 2005-06-09 2006-06-08 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
EP06754207A EP1901773B1 (en) 2005-06-09 2006-06-08 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
AT06754207T ATE548049T1 (en) 2005-06-09 2006-06-08 USE OF IDES PROTEINASE (FROM S. PYOGENES) TO TREAT AUTOIMMUNE DISEASES AND TRANSPLANT REJECTION
JP2008515137A JP5427409B2 (en) 2005-06-09 2006-06-08 Use of IdeS proteinase (derived from Streptococcus pyogenes) to treat autoimmune diseases and graft rejection
US11/921,770 US8133483B2 (en) 2005-06-09 2006-06-08 Method of treating or preventing a disease or condition mediated by pathogenic IgG antibodies
NL301089C NL301089I2 (en) 2005-06-09 2021-01-14 imlifidase
FR21C1004C FR21C1004I2 (en) 2005-06-09 2021-02-04 USE OF IDES PROTEINASE (FROM S. PYOGENES) FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND GRAFT REJECTION
BE2021C505C BE2021C505I2 (en) 2005-06-09 2021-02-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0605781A GB0605781D0 (en) 2006-03-22 2006-03-22 Treatment

Publications (1)

Publication Number Publication Date
GB0605781D0 true GB0605781D0 (en) 2006-05-03

Family

ID=36383991

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0605781A Ceased GB0605781D0 (en) 2005-06-09 2006-03-22 Treatment

Country Status (1)

Country Link
GB (1) GB0605781D0 (en)

Similar Documents

Publication Publication Date Title
IL196559A0 (en) Combination therapy
GB0602178D0 (en) Therapeutic treatment
GB0624874D0 (en) Treatment
IL196556A0 (en) Combination therapy
GB0718523D0 (en) Agricultural treatment
GB0711342D0 (en) Well treatment
EP2054061A4 (en) Combination therapy
ZA200809448B (en) Enzyme-microbe synergy
GB0600692D0 (en) Well treatment
ZA200902203B (en) Combination therapy
GB0608655D0 (en) Therapeutic Treatment
ZA200700875B (en) Water treatment
GB0716784D0 (en) Well treatment
GB0621527D0 (en) Acne treatment
GB0610909D0 (en) Therapeutic treatment
GB2444117B (en) Food treatment
GB0511769D0 (en) Treatment
GB0607952D0 (en) Novel treatment
GB0704392D0 (en) Water treatment
GB0604460D0 (en) Treatment
GB0710871D0 (en) Cancer treatment
GB0610431D0 (en) Treatment
GB0605781D0 (en) Treatment
GB0602857D0 (en) The treatment of sialorrhoea
GB0610376D0 (en) Therapeutic treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)